1 | Study | 1.3% | |
2 | Patients | 0.92% | |
3 | Disease | 0.88% | |
4 | Risk | 0.84% | |
5 | Health | 0.84% | |
6 | New | 0.84% | |
7 | Cancer | 0.79% | |
8 | May | 0.54% | |
9 | Times | 0.46% | |
10 | Treatment | 0.46% | |
11 | Therapy | 0.42% | |
12 | AI | 0.42% | |
13 | Chronic | 0.42% | |
14 | Hindustan | 0.42% | |
15 | HIV | 0.38% | |
16 | Blood | 0.38% | |
17 | Potential | 0.38% | |
18 | Diet | 0.33% | |
19 | Global | 0.33% | |
20 | Diabetes | 0.33% | |
21 | Outcomes | 0.33% | |
22 | Researchers | 0.33% | |
23 | According | 0.33% | |
24 | Impact | 0.33% | |
25 | Cell | 0.33% | |
26 | GLP-1 | 0.29% | |
27 | Type | 0.29% | |
28 | Liver | 0.29% | |
29 | Data | 0.29% | |
30 | Alzheimer’s | 0.29% | |
31 | Brain | 0.29% | |
32 | Use | 0.29% | |
33 | Test | 0.25% | |
34 | Semaglutide | 0.25% | |
35 | Research | 0.25% | |
36 | Linked | 0.25% | |
37 | Clinical | 0.25% | |
38 | Key | 0.25% | |
39 | Review | 0.25% | |
40 | Multiple | 0.25% | |
41 | Early | 0.25% | |
42 | Drugs | 0.25% | |
43 | Kidney | 0.25% | |
44 | Drug | 0.25% | |
45 | Syndrome | 0.21% | |
46 | Gene | 0.21% | |
47 | Medicine | 0.21% | |
48 | Psoriasis | 0.21% | |
49 | Fecal | 0.21% | |
50 | Obesity | 0.21% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Phase 2B ExTINGUISH Trial Aims to Assess Efficacy of Inebilizumab for NMDAR Encephalitis
NeurologyLive
2025-06-18 07:06:45
Nuravax Alzheimer’s Vaccine to Amyloid-Beta Is Safe, Immunogenic in Phase 1
Inside Precision Medicine
2025-06-17 22:25:29
Telehealth Geriatric Cancer Assessment Passes Phase III Test in Low-Resource Setting
MedPage Today
2025-06-17 06:38:56